EA200901391A1 - Пиримидинилпиперазины, применимые в качестве лигандов рецепторов d/d - Google Patents

Пиримидинилпиперазины, применимые в качестве лигандов рецепторов d/d

Info

Publication number
EA200901391A1
EA200901391A1 EA200901391A EA200901391A EA200901391A1 EA 200901391 A1 EA200901391 A1 EA 200901391A1 EA 200901391 A EA200901391 A EA 200901391A EA 200901391 A EA200901391 A EA 200901391A EA 200901391 A1 EA200901391 A1 EA 200901391A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrimidinylpyperazines
receptor ligands
relates
dopamine
polymorphs
Prior art date
Application number
EA200901391A
Other languages
English (en)
Other versions
EA016174B1 (ru
Inventor
Гизелла Бартане Салаи
Эва Агаине Чонгор
Дьёрдь Домань
Иштван Дьертьян
Бела Кишш
Юдит Ласи
Каталин Саги
Эва Шмидт
Шандор Фаркаш
Жолт Комлоди
Original Assignee
Рихтер Гедеон Нирт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Нирт. filed Critical Рихтер Гедеон Нирт.
Publication of EA200901391A1 publication Critical patent/EA200901391A1/ru
Publication of EA016174B1 publication Critical patent/EA016174B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к новым лигандам Dи Dдопамина формулы (I), где R1, R2 и Q имеют значения, указанные в описании, и/или к их геометрическим изомерам, и/или стереоизомерам, и/или диастереомерам, и/или солям, и/или гидратам, и/или сольватам, и/или полиморфам. Изобретение относится также к способам их получения, содержащим их композициям и их применению при лечении и/или профилактике состояний, которые требуют модуляцию рецепторов допамина.
EA200901391A 2007-04-11 2008-04-10 Пиримидинилпиперазины, применимые в качестве лигандов рецепторов d/d EA016174B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0700269A HUP0700269A2 (en) 2007-04-11 2007-04-11 Pyrimidinyl-piperazines useful as d3/d2 receptor ligands, pharmaceutical compositions containing them and their use
PCT/HU2008/000032 WO2008125891A2 (en) 2007-04-11 2008-04-10 Pyrimidinyl-piperazines useful as dopamine d3 /d2 receptor ligands

Publications (2)

Publication Number Publication Date
EA200901391A1 true EA200901391A1 (ru) 2010-02-26
EA016174B1 EA016174B1 (ru) 2012-02-28

Family

ID=38336883

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901391A EA016174B1 (ru) 2007-04-11 2008-04-10 Пиримидинилпиперазины, применимые в качестве лигандов рецепторов d/d

Country Status (36)

Country Link
EP (1) EP2132185B1 (ru)
JP (1) JP4580464B2 (ru)
KR (1) KR101540821B1 (ru)
CN (1) CN101652351B (ru)
AP (1) AP2460A (ru)
AT (1) ATE518843T1 (ru)
AU (1) AU2008237696B2 (ru)
BR (1) BRPI0809641A2 (ru)
CA (1) CA2682817C (ru)
CO (1) CO6241116A2 (ru)
CR (1) CR11071A (ru)
CU (1) CU23853B1 (ru)
CY (1) CY1111962T1 (ru)
DK (1) DK2132185T3 (ru)
EA (1) EA016174B1 (ru)
EC (1) ECSP099702A (ru)
ES (1) ES2370748T3 (ru)
GE (1) GEP20115272B (ru)
HK (1) HK1134491A1 (ru)
HR (1) HRP20110785T8 (ru)
HU (1) HUP0700269A2 (ru)
IL (1) IL200801A0 (ru)
MA (1) MA31359B1 (ru)
MX (1) MX2009010896A (ru)
MY (1) MY148384A (ru)
NI (1) NI200900179A (ru)
NZ (1) NZ579754A (ru)
PL (1) PL2132185T3 (ru)
PT (1) PT2132185E (ru)
RS (1) RS51979B (ru)
SI (1) SI2132185T1 (ru)
TN (1) TN2009000386A1 (ru)
TW (1) TWI445534B (ru)
UA (1) UA103748C2 (ru)
WO (1) WO2008125891A2 (ru)
ZA (1) ZA200906543B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9091489B2 (en) 2010-05-14 2015-07-28 Paragon Space Development Corporation Radiator systems
RS55645B1 (sr) * 2010-06-18 2017-06-30 Altos Therapeutics Llc Antagonisti d2, postupci za sintezu i postupci upotrebe
US9376396B2 (en) * 2012-10-22 2016-06-28 AbbVie Deutschland GmbH & Co. KG Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
HU229987B1 (en) * 2012-11-21 2015-04-28 Richter Gedeon Nyrt Process for the preparation of pyrimidinyl-piperazines
JP7015092B2 (ja) 2016-07-28 2022-02-02 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物
WO2019146739A1 (ja) 2018-01-26 2019-08-01 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する縮環化合物
US11447484B2 (en) 2018-01-26 2022-09-20 Shionogi & Co., Ltd. Cyclic compound having dopamine D3 receptor antagonistic effect
WO2024072930A1 (en) * 2022-09-30 2024-04-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dopamine d3/d2 receptor partial agonists for the treatment of neuropsychiatric disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2311776A1 (fr) 1975-05-23 1976-12-17 Sogeras Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
US5047406A (en) * 1989-12-06 1991-09-10 Warner-Lambert Co. Substituted cyclohexanols as central nervous system agents
US4957921A (en) 1989-12-06 1990-09-18 Warner-Lambert Company Substituted cyclohexanols as central nervous system agents
SE9802208D0 (sv) 1998-06-22 1998-06-22 Astra Pharma Inc Novel compounds
US6919342B2 (en) 2003-06-05 2005-07-19 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
EP1870405A1 (en) * 2006-06-22 2007-12-26 Bioprojet Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands

Also Published As

Publication number Publication date
CA2682817C (en) 2015-11-24
NZ579754A (en) 2011-11-25
AU2008237696A1 (en) 2008-10-23
RS51979B (en) 2012-02-29
HRP20110785T1 (hr) 2011-11-30
CO6241116A2 (es) 2011-01-20
ECSP099702A (es) 2009-11-30
KR20100082713A (ko) 2010-07-19
JP2010523642A (ja) 2010-07-15
CY1111962T1 (el) 2015-11-04
PL2132185T3 (pl) 2011-12-30
CU23853B1 (es) 2012-10-15
CA2682817A1 (en) 2008-10-23
MA31359B1 (fr) 2010-05-03
SI2132185T1 (sl) 2011-11-30
TWI445534B (zh) 2014-07-21
IL200801A0 (en) 2010-05-17
EP2132185B1 (en) 2011-08-03
AU2008237696B2 (en) 2013-03-14
AP2009004970A0 (en) 2009-10-31
DK2132185T3 (da) 2011-10-03
GEP20115272B (en) 2011-08-25
ES2370748T3 (es) 2011-12-22
NI200900179A (es) 2010-06-30
CU20090161A7 (es) 2011-09-21
ATE518843T1 (de) 2011-08-15
AP2460A (en) 2012-09-13
HU0700269D0 (en) 2007-05-29
PT2132185E (pt) 2011-11-21
HUP0700269A2 (en) 2009-04-28
JP4580464B2 (ja) 2010-11-10
TN2009000386A1 (en) 2010-12-31
CN101652351B (zh) 2012-07-04
KR101540821B1 (ko) 2015-07-30
BRPI0809641A2 (pt) 2014-11-11
MY148384A (en) 2013-04-15
WO2008125891A2 (en) 2008-10-23
UA103748C2 (ru) 2013-11-25
MX2009010896A (es) 2009-12-14
WO2008125891A3 (en) 2009-01-08
HRP20110785T8 (en) 2012-04-30
CR11071A (es) 2009-11-20
CN101652351A (zh) 2010-02-17
EP2132185A2 (en) 2009-12-16
EA016174B1 (ru) 2012-02-28
ZA200906543B (en) 2010-06-30
TW201002328A (en) 2010-01-16
HK1134491A1 (en) 2010-04-30

Similar Documents

Publication Publication Date Title
EA200901391A1 (ru) Пиримидинилпиперазины, применимые в качестве лигандов рецепторов d/d
EA200900606A1 (ru) Новые сульфониламидные производные в качестве антагонистов брадикининовых рецепторов
EA200970156A1 (ru) Пиридизиноновые производные
EA200970913A1 (ru) 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
MX2010001576A (es) Compuestos 3´sustituidos que tienen afinidad con el receptor 5-hidroxitriptamina 6 (5-ht6).
EA200970967A1 (ru) Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip)
MY146087A (en) Tricyclic compound, compositions, and methods
MX2009007075A (es) Metodos de uso para analogos de ciclopamina.
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA201291236A1 (ru) Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10
MY146924A (en) Substituted imidazoheterocycles
MX2010008375A (es) Derivados de piperidina espirocíclicos substituidos como ligandos de receptores de histamina-3 (h3).
EA200900605A1 (ru) Новые производные фенилсульфамоил бензамидов в качестве антагонистов брадикининовых рецепторов
EA201390163A1 (ru) Гетеробициклические производные в качетстве ингибиторов hcv
UA100877C2 (ru) Замещенные спироциклические производные пиперидина как лиганды рецепторов гистамина-3 (h3)
UA101602C2 (ru) Производные бензамидов как антагонисты брадикининовых рецепторов
EA201300436A8 (ru) Совместные кристаллы и соли ингибиторов ccr3
EA201190293A1 (ru) Пролекарства триптолида
MX2009012471A (es) Compuestos 4´sustituidos que tienen afinidad al receptor 5-hidroxitriptamina 6.
MX2019013979A (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
EA201591645A1 (ru) Hантагонисты, имеющие феноксипиперидиновое ядро в структуре
MX2009008028A (es) Agentes antiparasitarios.
WO2008088727A3 (en) Endothelin receptor antagonists
EA201170997A1 (ru) Производные индола в качестве противораковых агентов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM